STOCK TITAN

Agilent Technologies Inc. - A STOCK NEWS

Welcome to our dedicated news page for Agilent Technologies (Ticker: A), a resource for investors and traders seeking the latest updates and insights on Agilent Technologies.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Agilent Technologies's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Agilent Technologies's position in the market.

Rhea-AI Summary
Agilent Technologies Inc. (NYSE: A) to showcase innovative automation capabilities and transformative workflows at Analytica 2024 in Munich, Germany. The premier international trade fair for laboratory technology, analysis, and biotechnology will feature Agilent's latest innovations.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.66%
Tags
none
-
Rhea-AI Summary
Agilent Technologies Inc. (NYSE: A) will participate in the AACR Annual Meeting to showcase new cell analysis, genomics, and companion diagnostics solutions. Key products include NovoCyte Opteon Spectral Flow Cytometer, Avida target enrichment solutions, SureSelect Cancer Custom panels, and SureSelect CD CiberMed panels. Agilent emphasizes its commitment to advancing cancer research and patient outcomes through innovative technologies and partnerships.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.31%
Tags
none
-
Rhea-AI Summary
Agilent Technologies Inc. and UC San Diego collaborate to establish the Agilent Center of Excellence in Cellular Intelligence. The CoE aims to improve understanding of disease mechanisms at the cellular level, drive cell editing methods for disease treatment, immunity enhancement, and bioproduct creation. The initiative will leverage Agilent's instrumentation to support the Decode Eukaryotic Cellular Intelligence research program.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.95%
Tags
none
Rhea-AI Summary
Agilent Technologies Inc. (NYSE: A) introduces the Advanced Dilution System, ADS 2, an automation workflow solution to enhance laboratory efficiency. The system integrates with Agilent instruments and software, offering a comprehensive automated solution. With a focus on productivity and cost reduction, the ADS 2 optimizes analysis speed for various samples, ensuring data consistency and traceability.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.03%
Tags
none
-
Rhea-AI Summary
Agilent Technologies Inc. (NYSE: A) reveals Joycelyn Tan, a Ph.D. student at the University of Cambridge, UK, as the recipient of the Agilent Thought Leader Award for her innovative research in metabolic science.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.77%
Tags
none
-
Rhea-AI Summary
Crawford & Company (CRD) releases Q4 2023 financial results with a revenue decrease of 8% compared to 2022. GAAP net loss improved to $(0.8) million from $(14.1) million in 2022 Q4. Non-GAAP net income was $3.3 million in 2023 Q4, down from $11.4 million in the previous year. Full year 2023 showed a 7% revenue increase over 2022, with net income of $30.6 million compared to a loss of $(18.3) million in 2022.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.04%
Tags
none
Rhea-AI Summary
Agilent Technologies Inc. (NYSE: A) awards Distinguished Professors Michel Barsoum, Yury Gogotsi, and Ananda Amarasekara for their innovative research in advanced materials to enhance energy storage technology.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.26%
Tags
none
-
Rhea-AI Summary
Agilent Technologies Inc. (NYSE: A) reported Q1 revenue of $1.66 billion, down 5.6% reported and 6.4% core from last year. GAAP net income was $348 million, EPS $1.18, and non-GAAP net income $380 million, EPS $1.29. Full-year revenue outlook maintained at $6.710 - $6.810 billion with earnings guidance of $5.44 - $5.55 per share for FY 2024.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.36%
Tags
-
Rhea-AI Summary
Agilent Technologies Inc. (A) declares a quarterly dividend of 23.6 cents per share of common stock, payable on April 24, 2024, to shareholders of record as of April 2, 2024, subject to board approval.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.45%
Tags
dividends
Rhea-AI Summary
Agilent Technologies Inc. (NYSE: A) announces Padraig McDonnell as CEO-elect and COO, succeeding current CEO Mike McMullen. McDonnell, with nearly 40 years of experience, will take over on May 1, with McMullen retiring on Oct. 31. The transition reflects Agilent's strong leadership and succession planning.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.45%
Tags
none
Agilent Technologies Inc.

NYSE:A

A Rankings

A Stock Data

42.49B
291.88M
0.28%
91.58%
1.35%
Analytical Laboratory Instrument Manufacturing
Manufacturing
Link
US
Santa Clara

About A

analytical scientists and clinical researchers worldwide rely on agilent to help fulfill their most complex laboratory demands. our instruments, software, services and consumables address the full range of scientific and laboratory management needs—so our customers can do what they do best: improve the world around us. whether a laboratory is engaged in environmental testing, academic research, medical diagnostics, pharmaceuticals, petrochemicals or food testing, agilent provides laboratory solutions to meet their full spectrum of needs. we work closely with customers to help address global trends that impact human health and the environment, and to anticipate future scientific needs. our solutions improve the efficiency of the entire laboratory, from sample prep to data interpretation and management. customers trust agilent for solutions that enable insights...for a better world.